Background and Purpose-Intracerebral hemorrhage (ICH) is a devastating disease with a 30-day mortality of ~50%.
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ntracerebral hemorrhage (ICH) is a devastating form of stroke with 30% to 67% mortality and poor prognosis for which no effective therapy is available. 1, 2 Rapid deposition of blood within the brain parenchyma causes increased intracranial pressure, resulting in primary mechanical brain damage. Subsequently, various toxic blood components and hemolysis products within the hematoma trigger irreversible injury to the brain. Iron toxicity associated with oxidative stress, [3] [4] [5] or ferroptosis, 6 or HIF-1a (hypoxia-inducible factor 1 alpha), 7 could play a central role in this damage and ICH-associated inflammation. [8] [9] [10] [11] [12] After ICH, masses of polymorphonuclear neutrophils (PMNs) infiltrate into the ICH-affected brain parenchyma where they release various granule components during degranulation. [13] [14] [15] LTF (lactoferrin) is an iron-binding protein found in the secondary granules of PMNs. 16 Normally, LTF released by PMNs acts as a first-line defense protein against microbial pathogens through the chelation of iron. Structurally, LTF is a single-chain glycoprotein that folds into 2 lobes, and each lobe can tightly bind and sequester 1 ferric iron with high affinity (K d ≈10 −20 mol/L). 17, 18 Importantly, unlike other iron-binding proteins, LTF can retain ferric ions (Fe 3+ ) even at the low pH associated with inflamed tissue. This property can effectively prevent ferrous ions (Fe 2+ ) engagement in Fenton's reaction, a source of oxidative stress and inflammation. 19, 20 This is particularly important in ICH pathogenesis because after ICH, the erythrocytes (RBCs) in the hematoma undergo
LTF Degranulation Assay
Fresh PMNs in RPMI1640/10% mouse serum at 2×10 5 cells/mL were cultured in the CO2 incubator for 2 hours before being subjected to 15 minutes oxygen-glucose deprivation. 27 At 2 hours after reperfusion, or incubation with lysed RBC, or 1 μmol/L A23187 (calcium ionophore), culture medium was assessed for LTF with ELISA.
LTF Administration
mrLTF (mouse recombinant LTF) was injected intravenously at 10 mg/kg in 250 μL of saline (or saline alone/control), starting 3 hours after ICH, plus 5 mg/kg PO at 24 and 48 hours after ICH. For cell culture study, the mrLTF was added to the culture medium at 15 minutes before the insult.
Neurological/Functional Deficits and Edema Measurement
An individual test score and a combination test score (grand neurological deficit score) assumed an equal weight of each of the tests (Footfault, Forelimb Placing, Postural Flexing, Wire and Corner test). 24, 28 Brain edema was assessed with wet/dry method.
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RNA Isolation and Reverse TranscriptionPolymerase Chain Reaction
The dissected hematoma-affected striata were processed with Trizol Reagents for mRNA extraction. LTF primers (5′-cgaagcacgaatgacaaaga/3′-atcacacttgcgcttctcct) and GAPDH primers (5′-tgttcctacccccaatgtgt/3′-tgtgagggagatgctcagtg) were used for reverse transcription-polymerase chain reaction.
24,30
Western Blot LTF and GAPDH in the naive and ICH-affected striatum were determined as described. 24 Rabbit anti-LTF (bs-5810R; Bioss) or chicken anti-GAPDH (AB2302; Millipore) immunopositive bands were visualized using goat anti-rabbit IgG-horseradish peroxidase (Invitrogen) or goat anti-chicken IgG-horseradish peroxidase (Invitrogen) and chemiluminescence substrate (Pierce).
Immunofluorescence and Cell Counting
The immunohistochemistry for LTF and LTF/neutrophil double labeling on 10-μm-thick cryosections was performed as described earlier. 24 Rabbit anti-LTF (L3262; Sigma) and rat anti-mouse neutrophil antibody (ab53457; Abcam) were used to visualize LTF and PMNs. The nuclei were visualized with DAPI.
For PMNs counting, cryosections were generated at the level of needle insertion (site of blood injection). The total number of LTF + -PMNs on the digitized images representing whole striatum or PMNs on smears (from tail blood) was counted with CellSens (Olympus).
PMN Depletion in Mice After ICH
PMNs were depleted with rat monoclonal α-Ly-6G (lymphocyte antigen 6 complex locus G6D; BioXCell/BE0075) 500 μg/mouse IP at 24 and 48 hours after ICH, according to the validated protocol. 15, 31 A rat IgG2a isotype antibody (BioXCell/BE00892) served as the control. PMNs' depletion was verified with flow cytometry and microscopic morphology.
For flow cytometry, blood was collected via cardiac puncture. We stained cells with the following fluorophores (Tonbo-Bioscience): CD45-vf450, CD11b-APC-Cy7, Ly6G-Pe-Cy7, and Ly6C-APC. Data were acquired on a Cytoflex S cytometer (Beckmann Coulter) and analyzed by FlowJo Software (Tree Star). CD45 + /CD11b + /Ly6C-Intermediate/SSC-High was used to identify neutrophils. Gating strategy is described in Figure I in the online-only Data Supplement. We additionally performed a direct blood leukocyte classification and counting on Giemsa-stained tail blood smears using microscopic morphological features.
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Primary Cortical Neuron-Glial and Cortical Neuron Cultures
The primary neuron-glial cocultures from embryonic day 18-20 embryos from C57/BJ6 mice were prepared as we described. 29 The cortical neuron cultures from embryonic day 18 mouse embryos in Neurobasal medium with B27 were prepared as we described.
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ICH-Like Injury In Vitro
We exposed the 12-day-old cortical neuron-glial cocultures to RBC lysate (1 μL lysates/100 μL medium) in the presence/absence of mrLTF. Twenty hours later, cell viability was assessed with MTT reagent (G4000/Premega).
To simulate iron-induced neurotoxicity, we added FeCl 3 (1-100 μmol/L) to the 12-day-old cortical neurons in culture. This produced a dose-dependent neuronal death, with 50 μmol/L FeCl 3 causing 95% neuronal death within 24 hours. To determine the rLTF role in detoxifying iron, we incubated neurons with 10 μmol/L FeCl 3 for 6 hours with or without 20 μg/mL of mrLTF. The lactate dehydrogenase assay kit (G1780; Promega) was used to measure injury.
Statistical Analyses
We used GraphPad and InStat programs for statistical analyses. Oneway ANOVA followed by Newman-Keuls post-test was used for multiple comparisons. Paired t test was used when 2 groups were compared. Sample size was established based on our previous experience with this model.
Results
LTF Increases in Brain After ICH
Using immunofluorescence to label LTF + cells, we detected rare LTF + cells in the naive mouse brain or in the contralateral brain hemisphere of ICH-affected brain up to 14 days after ICH (data not shown). However, we detected a robust increase in the number of LTF + cells in the perihematoma/ hematoma territory after ICH ( Figure 1A and 1A'). Using double immunofluorescence staining for LTF and PMNs, we found that almost all of the LTF + cells found in the brain are PMNs ( Figure 1B ). The increase in LTF + cells became apparent at 6 hours after ICH, peaked at day 2, and slowly subsided over 14 days (Figure 2A and 2B). Corresponding to these immunohistochemical findings, Western blot showed LTF levels in the ICH-affected brain hemisphere increase robustly, showing many folds increase in brain LTF at day 2 after ICH, compared with naive ( Figure 2C ).
We emphasize that there is little detectable LTF mRNA in the naive mouse brain or in the ICH-affected brains at any time point after ICH, despite the ICH-induced increase in LTF protein (data not included). Furthermore, there is no detectable LTF mRNA found in purified peripheral blood PMNs (data not included). This is in agreement with the existing data that in contrast to bone marrow-derived developing PMNs, mature blood neutrophils primarily transport but do not transcribe LTF. [33] [34] [35] [36] [37] Taken together, these results suggest that the abundant amount of LTF found in the brain after ICH is delivered by mature, bone marrow-derived PMNs.
LTF Is Present in Peripheral PMNs and Is Released by PMNs on Exposure to RBC
Using fresh blood-purified mature PMNs, we demonstrated that LTF (normally packaged in the specific granules of PMNs) can be quickly released into the media on PMNs activation with RBCs or brief sublethal exposure to oxygenglucose deprivation ( Figure 3A) . Exposure to A23187, a calcium ionophore (capable of inducing degranulation), served as a positive control. These data suggest that RBCs and hypoperfusion (which often occurs secondary to ICH) can trigger degranulation and the release of LTF. However, the precise mechanism underlying this process is unknown.
It is intriguing to note that as a molecule that is normally stored in blood PMNs ( Figure 3B ), LTF after ICH was increased not only in the ICH-affected brain (site of PMNs infiltration) but also in the blood plasma ( Figure 3C ) and that the temporal profile of LTF increase in the blood and brain was very similar ( Figure 2B and 2C ). This suggests that ICH may also induce degranulation of circulating PMNs.
PMN Depletion After ICH Aggravates Neurological Deficits
Although earlier studies reported that PMN depletion before ICH is protective toward ICH-mediated damage, 38 the role of PMNs entering the brain at later stages after ICH is not known. In light of our recent studies demonstrating that the LTF levels in PMNs gradually increase after ICH, 15 we hypothesized that PMNs may exert beneficial effects in the later stages of ICH. To test this, we used a well-validated technique using systemic injection of anti-mouse Ly-6G neutralizing antibody to deplete systemic PMNs in mice. The isotype-matched antibody served as a control. 15, 39 Mice who received this neutralizing antibody at 24 and 48 hours after ICH became neutropenic, showing a robust 50% to 90% (depending on the method) depletion of peripheral PMNs ( Figure 4A and 4B) , as measures at 72 hours after ICH. These neutropenic mice showed 62% reduction in the circulating LTF level. Ultimately, we demonstrated that this delayed post-ICH depletion of PMNs worsens functional/neurological deficits as measured at day 3 after ICH ( Figure 4C ), suggesting that PMNs at later stages could play some beneficial role, for example, through delivery of LTF.
LTF Is Cytoprotective in an ICHLike Injury Model In Vitro
The neurotoxicity of products of hemolysis, including hemoglobin, heme, and iron, is an important component of ICHmediated brain damage. 40, 41 To clarify the role of LTF in RBC-induced cerebral toxicity, we added RBC lysate to the primary neuronal-glial cocultures 29 (an in vitro ICH-like injury model) containing mrLTF. As anticipated, we observed that RBC lysates caused severe neuronal damage, as showed using MTT assay, and that exogenously added mrLTF in a dose-dependent manner preserved the viability of cells exposed to RBC lysates ( Figure 5A ). To further explore the protective nature of LTF, we tested primary cultured neurons that were exposed to FeCl 3 . First, we established that FeCl 3 at 5 to 100 μmol/L induced dose-dependent neuronal injury, which was assessed by lactate dehydrogenase release assay (data not included). We then incubated cortical neurons with 10 μmol/L FeCl 3 (a dose which produces about 80% neuronal loss) in the presence or absence of 20 μg/mL mrLTF, demonstrating that LTF can robustly protect neurons from iron-induced injury ( Figure 5B ).
rLTF Protects Mice From Damage Caused by ICH
Encouraged by the neuroprotective capacities of mrLTF in the in vitro testing, we next examined whether mrLTF treatment conferred therapeutic benefit in a mouse model of ICH. We subjected mice to ICH and 3 hours later treated the mice with mrLTF (10 mg/kg IV, at 3 hours after ICH, plus 5 mg/kg, orally on days 1 and 2). We found that rLTF provided a robust benefit after ICH, reducing brain edema ( Figure 6A ) and neurological deficit-grand neurological deficit score (a composite score from 5 individual behavioral tests: Postural Flexing, Forward Placing, Footfault, Wire, and Circling) by 35.2% (11.4 versus 17.6; P≤0.05) on day 3 after ICH ( Figure 6A' ). Ultimately, we showed that the 24 hours delayed administration of mrLTF (10 mg/kg, orally on days 1-7) was effective in reducing the neurological deficit (12.2±0.7 versus 8.4±0.5; P<0.05), as assessed on day 7 after ICH ( Figure 6B ).
Discussion
In this study, we have demonstrated that the iron-binding protein LTF is normally present in the brain at very low levels and that ICH results in a robust and transient increase in brain LTF content. LTF detected in the brain was primarily identified in infiltrating PMNs that were seen in the brain areas directly affected by the ICH. Using in vitro models, we have demonstrated that ICH-like environments could induce PMNs to release LTF and that LTF added exogenously to the culture medium could protect brain cells in culture from toxicity induced by the product of hemolysis and iron. We also showed that the systemic depletion of PMNs using Ly-6G antibody 24 hours after ICH could exacerbate ICH outcome, suggesting that PMNs at later stages of ICH could contribute to the positive outcome, possibly in part by delivering cytoprotective LTF. Finally, we demonstrated that the mrLTF used as therapy for ICH was effective in reducing ICH-mediated damage when injected 3 hours after the ictus. Polymorphonuclear neutrophils (PMNs) depletion aggravates neurological deficits. To deplete PMNs, mice were injected with anti-Ly-6G, a neutrophil neutralizing antibody or isotype IgG at 500 μg/mouse at 24 and 48 hours after ICH (intraperitoneal; n=10 mice per group). The Ly-6G-mediated PMNs depletion at day 3 resulted in 50% to 70% reduction of PMNs while having negligible effect on lymphocytes (Lymph) or monocytes (mono), as determined on tail blood smears using microscopic morphological features (A); about 90% depletion as measured with flow cytometry using CD45 + /CD11b + /Ly6C-Intermediate/SSC-High as markers for gating on cardiac puncture-collected blood (B). The neurological deficit scores (NDS) were quantified with postural flexing and forward placing at 3 days after intracerebral hemorrhage (ICH; C). The data are mean±SEM. *P≤0.05 vs control. WBC indicates white blood cells. LTF is a glycoprotein and a member from the transferrin family. LTF is normally synthesized and released by mucosal tissues and PMNs, and PMNs specifically are known to be the key contributor to plasma LTF levels. 42 The initial objective of this study was to examine the time course and source of LTF in the brain after ICH. We found that LTF increases robustly within the initial 24 hours after ICH, reaching its highest level on day 2 and slowly declining within the next 2 weeks. Interestingly, this time profile is identical to the time profile of neutrophil infiltration to the brain after ICH, as we reported previously in a similar ICH model. 14 Thus, in conjunction with the present findings showing that all of the LTF-positive cells in ICH-affected brain are neutrophils, we think that the primary source of LTF in the brain after ICH are neutrophils. However, as LTF is also increased in the peripheral blood after ICH, it is likely that some of the LTF presents in the ICH-affected brain originates from the blood circulation. The origin of increased levels of LTF in peripheral blood after ICH was not investigated in this study; nevertheless, it is known that LTF can be readily released from circulating blood PMNs during any environmental insult, including trauma. 43 Indeed, experimentally induced neutropenia in this study reduced ICH-induced LTF increase. It has to be emphasized that in this study and in our earlier work, 15 LTF mRNA was very low both in the naive brain and in the brain after ICH, even when PMNs counts peaked in the brain. This suggests that local brain cells and mature infiltrating neutrophils have limited abilities to transcribe LTF and that LTF found in the brain is synthesized at other remote locations. This is in agreement with the notion that LTF synthesis and packaging into granules occurs during PMN maturation in bone marrow. [33] [34] [35] [36] [37] It is well accepted that LTF, besides its effect on iron sequestration, acts as a pleiotropic agent playing an important role of immune sensor, which directs specific immune responses and maintains immune homeostasis. 43 The level of LTF in blood is normally low (0.2-0.6 μg/mL), with a transient 100-fold increase on insult-induced activation of neutrophils. 44 After ICH, PMN infiltration into the ICH-affected brain has been proposed to augment local damage. 13, 31, 45 Indeed, the systemic depletion of neutrophils before ICH was shown to ameliorate ICH-mediated damage, 31 suggesting that the early infiltration of PMNs is deleterious. In contrast to the pre-ICH depletion paradigm, we found that late (24 hours) post-ICH PMN depletion is detrimental, suggesting the presence of some beneficial function of PMNs at this subacute stage of injury. One possibility, suggested by this study and our earlier findings, is that the PMNs can deliver cytoprotective LTF to the ICH-affected brain, neutralizing iron and blocking its toxicity. We have recently found that in response to ICH, microglia activated by this insult produce and release interleukin-27. Furthermore, interleukin-27 is elevated in the cerebra-spinal fluid and in peripheral blood after ICH, which could amplify production of LTF and haptoglobin and reduce expression of inducible nitric oxide synthase and matrix metalloproteinases in the maturing PMNs in bone marrow. 15 Thus, ICH can alter the phenotype of PMNs in a way that the PMNs entering brain at the later stages could have acquired augmented beneficial effects, including increased blood detoxification efficacy.
LTF is stored in the specific granules of PMNs and is normally released into the extracellular environment via degranulation to sequester hematoma-derived iron. Using PMNs harvested from blood, we demonstrated that PMNs release LTF on in vitro exposure to RBCs (the main component of an ICH hematoma). In addition, we showed that low, subinjurious oxygen-glucose deprivation (mimicking the moderate deficit in blood perfusion seen in the perihematoma area after ICH) can also augment LTF release from PMNs. Taken together, these results suggest that PMNs entering the ICH-affected brain may detect similar stimuli (blood products and mildly ischemic tissue), causing them to degranulate and release LTF.
Guided by the fact that PMN-delivered LTF could be beneficial to ICH pathobiology and our recent studies showing that LTF limits ICH-mediated injury, 15 we have now shown that rLTF blocks the toxicity of hemolytic products in mixed glianeuron culture and the toxicity of iron in primary neuronal culture. Similar to the human rLTF used in our earlier studies, mrLTF injected 3 hours after ICH could effectively limit ICH-mediated damage and specifically reduce brain edema and neurological deficit.
In conclusion, our present study demonstrates that LTF normally has a limited presence in the brain, but is delivered and released to the site of ICH injury by neutrophils. Moreover, LTF has potent capacity to limit iron-mediated cytotoxicity and protects the brain from injury caused by ICH.
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